Improvement of the Pharmacokinetics and in Vivo Antibacterial Efficacy of a Novel Type IIa Topoisomerase Inhibitor by Formulation in Liposomes
Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00163-13
Full Text
Open PDFAbstract
Available in full text
Date
July 22, 2013
Authors
Publisher
American Society for Microbiology